People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CodaMetrix Inc. | — | Other Health Care | Series C | $106.0M | $77.7M | 2025 |
| Daktari Diagnostics, Inc. | — | Biotechnology | Series B | $76.3M | $893.0M | 2009 |
| CoStim Pharmaceuticals Inc. | — | Pharmaceuticals | Series A | $10.0M | $309.9M | 2013 |
| Albamunity, Inc. | — | Pharmaceuticals | Series A | $5.0M | $154.6M | 2020 |
| Tilos Therapeutics, Inc. | — | Biotechnology | Seed | $3.8M | $135.4M | 2016 |
Roger Kitterman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roger Kitterman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jean-Francois Formela | 1 | 17 |
| Luke Evnin | 1 | 12 |
| David Rubin | 1 | 11 |
| SCOTT ROCKLAGE | 1 | 9 |
| John Edwards | 1 | 8 |
| Stanley Lapidus | 1 | 7 |
| Aaron Sandoski | 1 | 7 |
| Josh Resnick | 1 | 7 |
| Martin Heidecker | 1 | 6 |
| Meredith Fisher | 1 | 6 |
| Julius Knowles | 1 | 5 |
| Marian Nakada | 1 | 4 |
| Kazumi Shiosaki | 1 | 4 |
| Keith Kerman | 1 | 4 |
| Mark Pottle | 1 | 3 |
| DAVID ALLISON | 1 | 3 |
| Edward Roberts | 1 | 3 |
| Robert Millman | 1 | 3 |
| Todd Cozzens | 1 | 3 |
| Christopher Scoggins | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.